CLINICAL_TRIALS ClinicalTrials.gov record update

Double-blind, Randomized, Placebo Controlled Study Evaluating the Efficacy of Aerosal® in the Treatment of Inverse Psoriasis and Sebopsoriasis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01574872
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:48.433230+00:00
Published At: 2014-11-18T00:00:00+00:00
Record Updated At: 2014-11-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Inverse Psoriasis", "Sebopsoriasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2014-11-18"
protocolSection.identificationModule.nctId: "NCT01574872"
protocolSection.identificationModule.officialTitle: "Double-blind, Randomized, Placebo Controlled Study Evaluating the Efficacy of Aerosal\u00ae in the Treatment of Inverse Psoriasis and Sebopsoriasis"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.